These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1247523)

  • 1. Inhibition of bovine factor IXa and factor Xabeta by antithrombin III.
    Kurachi K; Fujikawa K; Schmer G; Davie EW
    Biochemistry; 1976 Jan; 15(2):373-7. PubMed ID: 1247523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of antithrombin III on the activity of the coagulation factors VII, IX and X.
    Osterud B; Miller-Andersson M; Abildgaard U; Prydz H
    Thromb Haemost; 1976 Apr; 35(2):295-304. PubMed ID: 61631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of human factor IXa by human antithrombin.
    Rosenberg JS; McKenna PW; Rosenberg RD
    J Biol Chem; 1975 Dec; 250(23):8883-8. PubMed ID: 1194266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A coagulation pathway on bovine aortic segments leading to generation of Factor Xa and thrombin.
    Stern DM; Nawroth PP; Kisiel W; Handley D; Drillings M; Bartos J
    J Clin Invest; 1984 Dec; 74(6):1910-21. PubMed ID: 6439737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prothrombin complex concentrates: potentially thrombogenic materials and clues to the mechanism of thrombosis in vivo.
    White GC; Roberts HR; Kingdon HS; Lundblad RL
    Blood; 1977 Feb; 49(2):159-70. PubMed ID: 12845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin and calcium ions dramatically enhance antithrombin reactivity with factor IXa by generating new interaction exosites.
    Bedsted T; Swanson R; Chuang YJ; Bock PE; Björk I; Olson ST
    Biochemistry; 2003 Jul; 42(27):8143-52. PubMed ID: 12846563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The factor IXa heparin-binding exosite is a cofactor interactive site: mechanism for antithrombin-independent inhibition of intrinsic tenase by heparin.
    Yuan QP; Walke EN; Sheehan JP
    Biochemistry; 2005 Mar; 44(9):3615-25. PubMed ID: 15736971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of factor IXa inhibition by antithrombin in the presence of unfractionated and low molecular weight heparins and fucoidan.
    Mauray S; de Raucourt E; Talbot JC; Dachary-Prigent J; Jozefowicz M; Fischer AM
    Biochim Biophys Acta; 1998 Sep; 1387(1-2):184-94. PubMed ID: 9748565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of pentosan polysulphate (SP54) and heparin. I: Mechanism of action on blood coagulation.
    Fischer AM; Barrowcliffe TW; Thomas DP
    Thromb Haemost; 1982 Apr; 47(2):104-8. PubMed ID: 6179182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The active site of antithrombin. Release of the same proteolytically cleaved form of the inhibitor from complexes with factor IXa, factor Xa, and thrombin.
    Björk I; Jackson CM; Jörnvall H; Lavine KK; Nordling K; Salsgiver WJ
    J Biol Chem; 1982 Mar; 257(5):2406-11. PubMed ID: 6977539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inhibition of activated bovine coagulation factors X and VII by antithrombin III.
    Jesty J
    Arch Biochem Biophys; 1978 Jan; 185(1):165-73. PubMed ID: 564164
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanism of inactivation of trypsin by antithrombin.
    Danielsson A; Björk I
    Biochem J; 1982 Oct; 207(1):21-8. PubMed ID: 6817749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of heparin and heparinlike molecules in thrombosis and atherosclerosis.
    Rosenberg RD
    Fed Proc; 1985 Feb; 44(2):404-9. PubMed ID: 3155697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depolymerized holothurian glycosaminoglycan and heparin inhibit the intrinsic tenase complex by a common antithrombin-independent mechanism.
    Sheehan JP; Walke EN
    Blood; 2006 May; 107(10):3876-82. PubMed ID: 16672689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of exosite occupancy by heparin to the regulation of coagulation proteases by antithrombin.
    Yang L; Manithody C; Qureshi SH; Rezaie AR
    Thromb Haemost; 2010 Feb; 103(2):277-83. PubMed ID: 20024502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo correlation of clotting protease activity: effect of heparin.
    Gitel SN; Stephenson RC; Wessler S
    Proc Natl Acad Sci U S A; 1977 Jul; 74(7):3028-32. PubMed ID: 268650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of heparin in the inactivation of thrombin, factor Xa, and plasmin by antithrombin III.
    Stürzebecher J; Markwardt F
    Thromb Res; 1977 Dec; 11(6):835-46. PubMed ID: 146278
    [No Abstract]   [Full Text] [Related]  

  • 18. Neutrophil elastase cleavage of human factor IX generates an activated factor IX-like product devoid of coagulant function.
    Samis JA; Kam E; Nesheim ME; Giles AR
    Blood; 1998 Aug; 92(4):1287-96. PubMed ID: 9694717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stable complex formation between serine protease inhibitor and zymogen: coagulation factor X cleaves the Arg393-Ser394 bond in a reactive centre loop of antithrombin in the presence of heparin.
    Nakatomi Y; Tsuji M; Gokudan S; Hanada-Dateki T; Nakashima T; Miyazaki H; Hamamoto T; Nakagaki T; Tomokiyo K
    J Biochem; 2012 Nov; 152(5):463-70. PubMed ID: 22923734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of activated porcine factor IX by dansyl-glutamyl-glycyl-arginyl-chloromethylketone.
    Lollar P; Fass DN
    Arch Biochem Biophys; 1984 Sep; 233(2):438-46. PubMed ID: 6435527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.